Marcie A Glicksman

USPTO Granted Patents = 19 (Patent Applications = 17)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 53(Granted Patents)

Location History:

Winchester, MA (US) (2012 - 2021)
Boston, MA (US) (2019 - 2024)

Company Filing History:

14 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

5 out of 262

Massachusetts Eye and Ear Infirmary

Dana-farber-cancer Institute Inc.

patents

5. 2 out of 2

Yuma Therapeutics, Inc.

patents

6. 1 out of 827

The Ohio State University

Aquinnah Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12115037 - Systems and methods of assisted reproduction and prevention of genetic defects in offspring using induced pluripotent stem cells (2024-10-15),

2. 12087399 - Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cells (2024-09-10),

3. 11692174 - Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial production (2023-07-04),

4. 11160808 - Compounds that enhance Atoh1 expression (2021-11-02),

5. 10961254 - Pyrimidine compounds and methods using the same (2021-03-30),

6. 10842822 - Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction (2020-11-24),

7. 10653676 - Small molecule inhibitors of USP1 deubiquitinating enzyme activity (2020-05-19),

8. 10406163 - Compounds that enhance Atoh1 expression (2019-09-10),

9. 10336768 - Pyrimidine compounds and methods using the same (2019-07-02),

10. 9556129 - Phosphatidylcholine transfer protein inhibitors (2017-01-31),

11. 9518032 - Small molecule inhibitors of USP1 deubiquitinating enzyme activity (2016-12-13),

12. 9447075 - Pyridazine derivatives as EAAT2 activators (2016-09-20),

13. 9433610 - Compounds that enhance Atoh1 expression (2016-09-06),

14. 9359363 - Identification of compounds that disperse TDP-43 inclusions (2016-06-07),

15. 9212209 - Screening methods for spinal muscular atrophy (2015-12-15),

Title: Marcie A Glicksman: Pioneering Innovations in Biotechnology

Introduction:

Marcie A Glicksman, a prominent inventor based in Boston, MA, is renowned for his unwavering passion for innovation and remarkable dedication to improving healthcare. With a remarkable portfolio of 17 patents, Glicksman has left an indelible mark in the biotechnology industry. His groundbreaking contributions continue to inspire budding inventors and researchers around the globe.

Latest Patents:

Among his latest patents is the revolutionary Systems, Methods, and Apparatus for Induced Pluripotent Stem Cell Isolation and Combinatorial Production. This innovative technology facilitates the systematic creation of isolated homogeneous colonies of cells from various vector-based lineages, paving the way for advancements in inducible pluripotent stem cell (iPSC) production. Additionally, Glicksman's invention of Compounds that Enhance Atoh1 Expression showcases his commitment to addressing diseases and disorders related to auditory impairments and abnormal cellular proliferation through targeted gene expression manipulation.

Career Highlights:

Having worked with esteemed institutions such as The Brigham and Women's Hospital, Inc. and Massachusetts Eye and Ear Infirmary, Glicksman has leveraged his expertise to drive forward cutting-edge research initiatives in the biotechnology realm. His illustrious career underscores a relentless pursuit of scientific excellence and a deep-seated commitment to revolutionizing healthcare through innovative solutions.

Collaborations:

Throughout his career, Glicksman has collaborated with distinguished professionals in the field, including Gregory Cuny and Lixin Qiao. These collaborative efforts have synergistically contributed to the development of groundbreaking technologies and propelled advancements in biotechnology research.

Conclusion:

In conclusion, Marcie A Glicksman's remarkable journey as an inventor in the biotechnology industry embodies a profound dedication to innovation and a relentless pursuit of excellence. His pioneering spirit and transformative inventions serve as a beacon of inspiration for the scientific community, paving the way for a brighter and healthier future.

This text is generated by artificial intelligence and may not be accurate.